key: cord-0797267-040xew55
authors: Dirr, McKenzie A.; Alam, Murad; Apfelbacher, Christian; Drewitz, Karl-Philipp; Kang, Bianca Y.; Munblit, Daniel; Nekliudov, Nikita; Seylanova, Nina
title: Improvements and advances in core outcome set methodology: proceedings of the CS-COUSIN & COMFA Joint Meeting
date: 2022-03-04
journal: Arch Dermatol Res
DOI: 10.1007/s00403-022-02341-3
sha: cb7b1c9f59261a6e2ba85b2caa61a0d2037bd5d3
doc_id: 797267
cord_uid: 040xew55

A COS is a systematically developed list of outcomes recommended for reporting all studies within a particular disease area. The Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) and the Core Outcome Measures in Food Allergy (COMFA) Initiative Joint Meeting was held virtually on September 23 through 28, 2021. This meeting brought together core outcome set (COS) developers within the domains of dermatology and food allergy, respectively. The meeting assessed the state of COS methodology, provided a forward look, and facilitated the networking of members of individual COS groups. The meeting hosted several expert-led key addresses and focus sessions, in which work was critically discussed, new developments were shared, and groundwork was laid for future projects. The conference emphasized the importance of ongoing COS work to improve patient outcomes and limit research waste.

The methodology for core outcome set development has continued to evolve over the past decade. Work has been done to produce core outcome sets that are inclusive and generalizable, and ensure the development process minimizes the introduction of the specific biases of the various stakeholders [2, 10, 13, 15] . In particular, the patient perspective is recognized as extremely important. Further advances in core outcome set methodology were discussed at the recent Cochrane Skin-Core Outcome Set Initiative (CS-COUSIN) and Core Outcome Measures in Food Allergy (COMFA) Initiative Joint Meeting, held virtually September 23 through 28, 2021 in Magdeburg, Germany (https:// cconl ine. event sair. com/ cs-cousin/) [9] . Both CS-COUSIN and COMFA are dedicated to the development of core outcome sets (COSs), which are standardized minimum outcomes for reporting findings from clinical trials and other studies within a given disease area [14, 18] . CS-COUSIN is an umbrella organization for COS groups which develop dermatological outcome 1 3 sets, while the COMFA Initiative develops core outcomes related to food allergies [7, 9, 14] . COMFA is a COST Action (CA18227), which receives funding supported by COST (European Cooperation in Science and Technology, www. cost. eu) [8] . The conference was jointly chaired by Professor Christian Apfelbacher (CS-COUSIN, co-chair of HOME and HECOS and grand holder scientific representative of COMFA) and Dr. Daniel Munblit (COMFA chair).

The overall aim of this conference was to apprise researchers of the state of COS development and to provide a space for researchers in the field of COS methodology to learn from the experiences of others [9] . Attendees were afforded opportunities for collaboration and to progress their own work through dedicated focus sessions [9] . Additionally, COMFA hosted a training school, which aimed to provide supplementary guidance and support for early researchers [9] .

Core outcome sets are developed to guide future studies within a given disease area to consider the most important factors as rated by physicians, patients, and other stakeholders alike [14, 18] . The goal of COS work is to increase consistency of outcome reporting within a disease area, as well as provide a unified consideration of the most important outcomes as perceived by stakeholders [18] . In doing so, there will be uniform trial outcome analysis, as well as ensured consistency between reported results [18] . The Core Outcome Measures in Effectiveness Trials (COMET) Initiative, a leading initiative in the field of COS, as well as CS-COUSIN, have established informational guidelines and helpful material for standardized stages in COS development that all project groups are encouraged to use [6, 14] . Additionally, the HOME (Harmonizing Outcome Measures for Eczema) roadmap provides dermatological COS projects a useful outline on which to build a sound outcome set [1, 16] . This communication provides a brief summary of the highquality work that was done within the working groups, as well as the collective experience of the conference attendees. [17] . This was followed by an in-depth discussion of the ongoing development of a core outcome set for Long COVID, details of which can be found on the COMET database [11] . . With the diverse topics covered in the plenary sessions for all attendees, there was ample opportunity for groups to glean generalizable information that can provide groundwork to facilitate discussion and momentum, as well as directive advice for those who are just beginning the process of such an undertaking.

Project groups were allotted focus session time to further the progress of their work through one of three key objectives, which included: reaching consensus on domains/ subdomains/outcomes, or agreement on a given problem; discussion of major achievements or progress that has been made; identification of next steps and best approaches [9] . In addition, each group was invited to describe this progress at the final day plenary session as a way to demonstrate key ideas which may prove useful to other participants. Groups in attendance and who provided a summary presentation included COSCAM, CORALS, HECOS, COMFA, HOME, IMPROVED, and UPGRADE, each of which is described in detail in Table 1 .

To summarize the high-quality work that was done over the course of the conference, each working group was invited to provide a presentation regarding the activities and key takeaways of their focus session. These provided insight into challenges, strategies, and successes, facilitated communication, and created a community of shared knowledge among groups. The first speaker, Dr. Ginger Beau Langbroek from the Department of Surgery at Amsterdam University Medical Centers, provided a high-level overview of COSCAM (Core Outcome Set for CApillary Malformations (COSCAM) [4] . She described COSCAM's methods and results, with detailed results of participants, outcomes for voting, and the final successful development of a core domain set for capillary malformations. Dr. Rosalind Simpson, associate professor at the Centre of Evidence-Based Dermatology at the University of Nottingham School of Medicine, spoke on behalf of CORALS (Core outcomes for research in lichen sclerosus) [4] . She described where the group stands in the development phase, as well as the fruitful discussion held during the focus session. This included discussion surrounding the need to increase diversity and expand across more international areas, as well as the need to include adverse events in outcome sets. CORALS also noted the importance of maintaining momentum, which applies to all other project developers. Dipl.-Soz. Henriette Rönsch, Department of Dermatology of the University Hospital Carl Gustav Carus Technical University of Dresden, presented on behalf of HECOS (Development of a core outcome set for hand eczema) and gave a detailed overview of the progress that was made during the course of the conference [4] . Firstly, HECOS ratified and discussed the long list of outcomes that will be used in the Delphi Process, which consists of multiple rounds of surveys which collect ratings of importance for every outcome to ultimately determine the final list of outcomes following a final consensus meeting and vote. She also detailed thorough discussion of definitions, and the next steps of this project, which include translating the list into more than one language and increasing the number of patient participants. On behalf of COMFA, Dr. Daniel Munblit gave an overview of the systematic review that was performed, as well as a detailed description of the ongoing projects, with a conference output of finalized protocol development. In addition, the COMFA training school was a highly productive introduction to COS methodology for budding researchers or professionals that are new to the field of core outcome methodology, and covered systematic reviews, foundations of COS development, and [4] effective management of a COS development project. Prof. Kim Thomas, Centre of Evidence-Based Dermatology of the Queen's Medical Centre, University of Nottingham Faculty of Medicine and Health Sciences, and a leading member of HOME, reviewed the goals of the conference focus session, specifically the importance of "supporting implementation of the COS," which HOME has successfully developed. As a collective group, they implemented pre-meeting surveys to identify opportunities or challenges in application and use of the COS. They subsequently held small-group discussions regarding the most important areas of focus, after which everyone had the opportunity to present an idea on how to overcome or address this challenge. Next, Bianca Younseon Kang, medical student at Creighton University School of Medicine, presented on behalf of the IMPROVED Group (Measurement of Priority Outcome Variables in Dermatologic Surgery) [4] . Ms. Kang presented a summary of the pre-Delphi kickoff workshop held with international physicians and researchers to present key ideas regarding conduct of an international COS and facilitation of a virtual consensus meeting. At the workshop, the results of a systematic review were evaluated, and attendees provided input regarding the most important questions to ask, the importance of involving patients and other important stakeholders in a similar workshop, and the need to include all specialties in the study. Finally, Dr. Alex G. Ortega-Loayza, Oregon Health and Science University School of Medicine associate professor of Dermatology, presented the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Analysis of Disease Effects) working group discussion, which included "generation of items" for the long list of outcomes, as well as "domain classification", i.e., which outcomes would fall into which domain category for Delphis [4] . The conference was an opportunity for UPGRADE to identify challenges and receive feedback, specifically on expanding and diversifying expert and patient involvement.

The CS-COUSIN & COMFA Joint Meeting was an opportunity for research professionals, physicians, and patients to come together to advance the development of core outcome sets and improve the associated methodology. The conference allowed individual working groups an opportunity to address important challenges and next steps. Individual COS groups also shared the status of their work with the larger group of conference participants. The merger of CS-COUSIN and CHORD into a unified organization, C3, was announced as an important step toward providing dermatology COS developers a cohesive parent organization. Key take-home messages included the importance of sound methodological preparation early in the COS development planning stages; the need to include all stakeholder groups, including patients, in every phase of the process; and the importance of plans for uptake of COS work once produced.

Core outcome sets and core outcome measures: a primer

Cochrane Skin -Core outcome set initiative. COS project groups. Cochrane Skin -Core Outcome Set Initiative

Cochrane Skin -Core outcome set initiative. CS-COUSIN Home Page

Comet initiative: the core outcome measures for food allergy. COMET Initiative. The core outcome measures for food allergy

European cooperation in science and technology. COST -European Cooperation in Science & Technology

CS-Cousin Meeting-Cochrane Skin-Core Outcome Set Initiative

Postinflammatory hyperpigmentation: protocol for development of a core outcome set for clinical trials

Comet initiative: core outcome measures for post-covid condition/long covid. COMET Initiative. Core Outcome Measures for Post-Covid condition/Long Covid

Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative

Navigating the landscape of core outcome set development in dermatology

Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes

The harmonizing outcome measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology

Core outcomes set for trials in people with Coronavirus Disease

COMET Plain Language Summary

Acknowledgements This article/publication is partly based upon work from COST Action COMFA, CA18227, supported by COST (European Cooperation in Science and Technology), www. cost. eu.Funding None.

Code availability Not applicable.